Represented Jatt Acquisition Corp. in its $165 million business combination with Zura Bio

Represented JATT Acquisition Corp., a special purpose acquisition company, in its $165 million business combination with Zura Bio, a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorder.